×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SUPN – supernus pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SUPN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/19
07:15 am
supn
Newron Announces Agreement With the European Investment Bank (EIB) to Extend the Near-Term Tranche Repayment Dates of Its 2018 Finance Contract [Yahoo! Finance]
Low
Report
Newron Announces Agreement With the European Investment Bank (EIB) to Extend the Near-Term Tranche Repayment Dates of Its 2018 Finance Contract [Yahoo! Finance]
3/12
10:35 am
supn
3 Reasons SUPN is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
3 Reasons SUPN is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
3/11
03:58 pm
supn
Supernus Pharmaceuticals, Inc. (SUPN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Neutral
Report
Supernus Pharmaceuticals, Inc. (SUPN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/8
01:31 am
supn
Supernus Pharmaceuticals (SUPN) was downgraded by Wall Street Zen fro
Low
Report
Supernus Pharmaceuticals (SUPN) was downgraded by Wall Street Zen fro
2/25
11:09 am
supn
Supernus Pharmaceuticals (SUPN) was given a new $65.00 price target by Craig Hallum.
Low
Report
Supernus Pharmaceuticals (SUPN) was given a new $65.00 price target by Craig Hallum.
2/25
04:30 am
supn
Supernus Pharmaceuticals, Inc. (SUPN) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Supernus Pharmaceuticals, Inc. (SUPN) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/25
12:27 am
supn
Supernus Pharmaceuticals Inc (SUPN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
Low
Report
Supernus Pharmaceuticals Inc (SUPN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
2/24
05:32 pm
supn
Supernus Pharmaceuticals's (NASDAQ:SUPN) Q4 CY2025: Strong Sales [Yahoo! Finance]
Medium
Report
Supernus Pharmaceuticals's (NASDAQ:SUPN) Q4 CY2025: Strong Sales [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
2/24/2026
04:05 pm
supn
supernus pharmaceuticals, inc.
MISS
Report
2.4%
supernus pharmaceuticals, inc.
11/4/2025
04:01 pm
supn
supernus pharmaceuticals, inc.
MISS
Report
-17.4%
supernus pharmaceuticals, inc.
8/5/2025
04:05 pm
supn
supernus pharmaceuticals, inc.
BEAT
Report
13.1%
supernus pharmaceuticals, inc.
5/6/2025
04:08 pm
supn
supernus pharmaceuticals, inc.
MISS
Report
-4.6%
supernus pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/18
05:18 pm
supn
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 16 Filed by: Bhatt Padmanabh P.
Low
Report
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 16 Filed by: Bhatt Padmanabh P.
3/17
04:30 pm
supn
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Bhatt Padmanabh P.
Medium
Report
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Bhatt Padmanabh P.
3/16
04:38 pm
supn
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Bhatt Padmanabh P.
Low
Report
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Bhatt Padmanabh P.
3/16
04:08 pm
supn
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 13 Filed by: Khattar Jack A.
Low
Report
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 13 Filed by: Khattar Jack A.
3/16
04:08 pm
supn
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 12 Filed by: Hudson Frederick M.
Low
Report
Form 4 SUPERNUS PHARMACEUTICALS For: Mar 12 Filed by: Hudson Frederick M.
3/13
04:22 pm
supn
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Khattar Jack A.
Low
Report
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Khattar Jack A.
3/12
04:07 pm
supn
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Hudson Frederick M.
Low
Report
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Hudson Frederick M.
3/10
04:18 pm
supn
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Horich William Todd
Low
Report
Form 144 SUPERNUS PHARMACEUTICALS Filed by: Horich William Todd
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/28
Supernus to Acquire CNS Portfolio from US WorldMeds
19.0%
3/30 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.8%
11/7 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. 6.1%
4/3 Form 8-K SUPERNUS PHARMACEUTICALS For: Mar 30 5.7%
11/8 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at Berenberg Bank from a "buy" rating to a "hold" rating. 5.1%
8/27 Form 4 SUPERNUS PHARMACEUTICALS For: Aug 23 Filed by: Khattar Jack A. 5.1%
3/30 Supernus Provides Business Update 4.8%
3/4 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 4.4%
6/25 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 4.0%
4/24 Supernus to Host First Quarter Results Earnings Conference Call 3.3%
3/30 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.8%
11/7 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. 6.1%
4/3 Form 8-K SUPERNUS PHARMACEUTICALS For: Mar 30 5.7%
11/8 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at Berenberg Bank from a "buy" rating to a "hold" rating. 5.1%
8/27 Form 4 SUPERNUS PHARMACEUTICALS For: Aug 23 Filed by: Khattar Jack A. 5.1%
3/30 Supernus Provides Business Update 4.8%
3/4 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 4.4%
6/25 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 4.0%
4/24 Supernus to Host First Quarter Results Earnings Conference Call 3.3%
TOP News Decliners
11/5
Q3/2019 9/30/2019 EPS 0.540 ZacksConsensus 0.590 ActVsEst (0.050) - Miss
-31.6%
8/6 Q2/2019 6/30/2019 EPS 0.610 ZacksConsensus 0.560 ActVsEst 0.050 - Beat -15.0%
2/25 Supernus Announces Fourth Quarter and Full Year 2019 Financial Results -14.9%
2/26 Why Supernus Pharmaceuticals Plunged 15% Today [The Motley Fool] -7.8%
8/27 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -4.0%
5/7 Form 8-K SUPERNUS PHARMACEUTICALS For: May 07 -3.5%
5/29 Supernus to Present at the Jefferies 2019 Global Healthcare Conference -3.5%
9/25 Form 8-K SUPERNUS PHARMACEUTICALS For: Sep 25 -3.4%
1/23 Form 8-K SUPERNUS PHARMACEUTICALS For: Jan 21 -2.6%
4/30 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) had its price target raised by analysts at Piper Sandler from $17.00 to $25.00. They now have a "neutral" rating on the stock. -2.5%
8/6 Q2/2019 6/30/2019 EPS 0.610 ZacksConsensus 0.560 ActVsEst 0.050 - Beat -15.0%
2/25 Supernus Announces Fourth Quarter and Full Year 2019 Financial Results -14.9%
2/26 Why Supernus Pharmaceuticals Plunged 15% Today [The Motley Fool] -7.8%
8/27 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -4.0%
5/7 Form 8-K SUPERNUS PHARMACEUTICALS For: May 07 -3.5%
5/29 Supernus to Present at the Jefferies 2019 Global Healthcare Conference -3.5%
9/25 Form 8-K SUPERNUS PHARMACEUTICALS For: Sep 25 -3.4%
1/23 Form 8-K SUPERNUS PHARMACEUTICALS For: Jan 21 -2.6%
4/30 Supernus Pharmaceuticals Inc (NASDAQ: SUPN) had its price target raised by analysts at Piper Sandler from $17.00 to $25.00. They now have a "neutral" rating on the stock. -2.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: